Richard R. de Haas

Amsterdam University Medical Centers — Netherlands

Medicine · Health Sciences

17h-index1.2kcitations49works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(12), Pancreatic and Hepatic Oncology Research(9), Advanced Proteomics Techniques and Applications(6), Advanced biosensing and bioanalysis techniques(4), Angiogenesis and VEGF in Cancer(4)

Publications49 total

Discovery of dementia type specific biomarkers with untargeted CSF proteomics
Alzheimer s & Dementia·2024Open Access
The translatome of glioblastoma
Molecular Oncology·2024Open Access
Author response for "The translatome of glioblastoma"
2024
Author response for "The translatome of glioblastoma"
2024
Author response for "The translatome of glioblastoma"
2024
Abstract 6485: Profile guided low dose drug combination strategies and kinase activities with prognostic and therapeutic avenues in pancreatic ductal adenocarcinoma
Cancer Research·2024
Data from Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
2023Open Access
Data from Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
2023Open Access
Supplementary Figures 1-3 from Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
2023Open Access
Supplementary Figures 1-3 from Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
2023Open Access
The translatome of Glioblastoma multiforme
2023Open Access
The translatome of Glioblastoma multiforme
2022Open Access
Feasibility of phosphoproteomics to uncover oncogenic signalling in secreted extracellular vesicles using glioblastoma-EGFRVIII cells as a model
Journal of Proteomics·2020· 13 cited
Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment
Molecular Oncology·2020· 29 citedOpen Access
<scp>INKA</scp> , an integrative data analysis pipeline for phosphoproteomic inference of active kinases
Molecular Systems Biology·2019· 49 citedOpen Access
<scp>INKA</scp> , an integrative data analysis pipeline for phosphoproteomic inference of active kinases
Molecular Systems Biology·2019· 101 citedOpen Access
Comparison of phosphoproteomic profiles in left- and right-sided colorectal cancers.
Journal of Clinical Oncology·2019
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active phosphokinases
2018· 3 citedOpen Access
Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth
Journal of Experimental & Clinical Cancer Research·2016· 21 citedOpen Access
Mass spectrometry-based phosphoproteomics of tumor needle biopsies from patients (pts) with advanced solid tumors during treatment with protein kinase inhibitors.
Journal of Clinical Oncology·2016
page 1 of 3Next →

Frequent Co-authors

Henk M.W. Verheul(23), Sander R. Piersma(18), Connie R. Jiménez(17), Henk J. Broxterman(16), Henk Dekker(14), Mariëtte Labots(12), Kristy J. Gotink(10), Richard J. Honeywell(10), Godefridus J. Peters(10), Thang V. Pham(10), Arjan W. Griffioen(9), Роберто Пили(8), Jaco C. Knol(8), Yehuda G. Assaraf(6), Robin Beekhof(6), Fleur M.G. Cornelissen(6), David P. Noske(6), W. Peter Vandertop(6), Cornelis Murre(6), Michelle A. Rudek(5)